Company profile: Diamondback Drugs
1.1 - Company Overview
Company description
- Provider of custom compounded veterinary medications and dosage forms for clinics, hospitals, zoos, aquariums, research institutions, and pet owners. Products include flavored medications, Medi-Melts, Tiny Tabs, transdermal gels, and otic treatments. Equipped with state-of-the-art compounding equipment; staff trained in basic compounding and sterile injectables.
Products and services
- Custom Veterinary Medications: Custom-compounded prescriptions in various strengths and dosage forms, including sterile injectables, tailored to veterinary patients across species and conditions using state-of-the-art equipment
- Transdermal Medications: Pharmaceutical-grade gel formulations absorbed through the skin, offering an alternative for pets that resist oral medications and simplifying dosing for caregivers
- Flavored Medications: Flavor-engineered veterinary medications available in multiple palatable flavors, improving acceptance and simplifying administration for pet owners and veterinarians.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Diamondback Drugs
Medsen Apotheken
HQ: The Netherlands
Website
- Description: Provider of pharmacy services via 50+ pharmacies in the Netherlands, delivering accessible, expert care. Offers repeat medication service, 24-hour pickup machines, and Mijn Medsen for secure access to records and repeat prescriptions. Supplies medical devices, contracts with all health insurers, and manages medicine shortages by sourcing alternatives and preparing medications in-house.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medsen Apotheken company profile →
Xubex
HQ: United States
Website
- Description: Provider of professional pharmaceutical services and patient assistance program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xubex company profile →
Guardian Pharmacy
HQ: United States
Website
- Description: Provider of medication management services for long-term pharmacy care, including medication dispensing and delivery, EHR integration, and billing and insurance support. Offers 24/7 emergency medication services, clinical support, robotic dispensing, smart packaging to improve adherence, and data analytics for operational insights.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Guardian Pharmacy company profile →
Uvanta
HQ: United States
Website
- Description: Provider of a unique opportunity to open and independently operate your own institutional pharmacy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Uvanta company profile →
QOL Meds
HQ: United States
Website
- Description: Provider of behavioral health specialty pharmacy services at community mental health centers and federally qualified health centers in the United States, offering medications, pharmacy filling, monthly billing, customized packaging, medication education for consumers, and a patient assistance program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QOL Meds company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Diamondback Drugs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Diamondback Drugs
2.2 - Growth funds investing in similar companies to Diamondback Drugs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Diamondback Drugs
4.2 - Public trading comparable groups for Diamondback Drugs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →